Reference
Peptide legality in Europe
Whether a peptide can be handled as a research chemical varies by country and by compound. This is a neutral, sourced overview of how each of the 35 peptides on this site is classified in 17 major European markets — a representative set we track, not an exhaustive list of Europe — covering both what is restricted and what is not specifically banned.
How to read this
Across Europe there is no single “research chemical” licence. A peptide is generally lawful to handle as a genuine laboratory reagent only while it is not a controlled substance, not specifically named in an anti-doping or medicines schedule, and not presented or intended for human use. Under EU medicines law — and the equivalent UK (MHRA) and Swiss (Swissmedic) regimes — a substance becomes an unauthorised medicine the moment it is intended for human consumption. So “legal as research” and “legal to take” are not the same thing. Anti-doping status is a separate sporting matter, shown as a “Prohibited in sport (WADA)” flag on each compound (see the full list): it governs what competing athletes may use and does not by itself make a substance illegal to possess or handle.
- Approved medicine. Authorised as a prescription medicine in this market (used under medical supervision). This applies only to the specific authorised product, and does not make research-grade or unprescribed material of the same molecule lawful to use.
- Restricted. This compound is specifically scheduled, named in anti-doping law, or actively treated as an unauthorised medicine in this country — a specific legal barrier beyond the general research-reagent position. Do not assume it is lawful to supply or handle here, even for research, and it is never lawful for human use.
- No specific ban (research reagent only). Not a controlled substance and not specifically scheduled in this country, so handling it as a genuine not-for-human-use laboratory reagent is not specifically prohibited. This is not a positive authorisation, and it does not make human use lawful.
- Unclear. Could not be determined from available sources; treat conservatively.
Legality by country
Spain
Spain has no dedicated research-chemical statute. A peptide that is not a controlled substance and not specifically scheduled is not prohibited to handle as a genuine laboratory reagent — but Spanish medicines law (RDL 1/2015) classifies anything intended or presented for human use as a medicine requiring AEMPS authorisation, and anti-doping law (LO 11/2021) covers substances supplied to athletes.
Approved medicines (6): Gonadorelin, Liraglutide, Melanotan I, Oxytocin, Semaglutide, Tirzepatide
Restricted (14): AOD-9604, Cerebrolysin, CJC-1295, GHRP-2, GHRP-6, Hexarelin, Ipamorelin, Kisspeptin, Melanotan II, MOTS-c, Sermorelin, TB-500, Tesamorelin, Thymosin beta-4
No specific ban (research reagent only) (15): BPC-157, Cagrilintide, DSIP, Epitalon, GHK-Cu, Humanin, KPV, LL-37, PT-141, Retatrutide, Selank, Semax, SS-31, Thymalin, Thymosin alpha-1
Germany
Germany is among the strictest in the EU. The Medicines Act (AMG) treats pharmacologically active peptides as medicines regardless of a “research only” label, and many growth-hormone and anabolic peptides are named in the Anti-Doping Act (AntiDopG). Most non-approved peptides here are unauthorised medicines.
Approved medicines (6): Cerebrolysin, Liraglutide, Melanotan I, Oxytocin, Semaglutide, Tirzepatide
Restricted (12): AOD-9604, CJC-1295, GHRP-2, GHRP-6, Gonadorelin, Hexarelin, Ipamorelin, Melanotan II, Sermorelin, TB-500, Tesamorelin, Thymosin beta-4
No specific ban (research reagent only) (17): BPC-157, Cagrilintide, DSIP, Epitalon, GHK-Cu, Humanin, Kisspeptin, KPV, LL-37, MOTS-c, PT-141, Retatrutide, Selank, Semax, SS-31, Thymalin, Thymosin alpha-1
France
France (ANSM) reads the definition of a medicine broadly, and a 2024–2025 possession order names several peptides directly. Most non-approved peptides are treated as unauthorised medicines, and promotion to the public is separately prohibited.
Approved medicines (5): Liraglutide, Melanotan I, Oxytocin, Semaglutide, Tirzepatide
Restricted (15): AOD-9604, Cerebrolysin, CJC-1295, GHRP-2, GHRP-6, Gonadorelin, Hexarelin, Ipamorelin, Kisspeptin, Melanotan II, MOTS-c, Sermorelin, TB-500, Tesamorelin, Thymosin beta-4
No specific ban (research reagent only) (15): BPC-157, Cagrilintide, DSIP, Epitalon, GHK-Cu, Humanin, KPV, LL-37, PT-141, Retatrutide, Selank, Semax, SS-31, Thymalin, Thymosin alpha-1
Italy
Italy treats most non-approved peptides as unauthorised medicines and reproduces the WADA list under Law 376/2000, so growth-hormone and anabolic peptides are caught. Few of these compounds are unscheduled.
Approved medicines (6): Liraglutide, Melanotan I, Oxytocin, Semaglutide, Thymosin alpha-1, Tirzepatide
Restricted (15): AOD-9604, Cerebrolysin, CJC-1295, GHRP-2, GHRP-6, Gonadorelin, Hexarelin, Ipamorelin, Kisspeptin, Melanotan II, MOTS-c, Sermorelin, TB-500, Tesamorelin, Thymosin beta-4
No specific ban (research reagent only) (14): BPC-157, Cagrilintide, DSIP, Epitalon, GHK-Cu, Humanin, KPV, LL-37, PT-141, Retatrutide, Selank, Semax, SS-31, Thymalin
Netherlands
The Netherlands does not schedule most peptides under the Opium Act, but the Medicines Act (Geneesmiddelenwet) and the IGJ regulator treat human-use-intended peptides as unauthorised medicines. Genuine laboratory reagents sit in a narrow gap.
Approved medicines (6): Gonadorelin, Liraglutide, Melanotan I, Oxytocin, Semaglutide, Tirzepatide
Restricted (2): Cerebrolysin, Melanotan II
No specific ban (research reagent only) (27): AOD-9604, BPC-157, Cagrilintide, CJC-1295, DSIP, Epitalon, GHK-Cu, GHRP-2, GHRP-6, Hexarelin, Humanin, Ipamorelin, Kisspeptin, KPV, LL-37, MOTS-c, PT-141, Retatrutide, Selank, Semax, Sermorelin, SS-31, TB-500, Tesamorelin, Thymalin, Thymosin alpha-1, Thymosin beta-4
Poland
Poland does not schedule most peptides as controlled substances, but a 2025 GIF/GIS public warning states that offering synthetic peptides as “research reagents” is contrary to Polish law where they are in fact intended for human use. The Pharmaceutical Law treats human-use-intended peptides as unauthorised medicines, and the 2017 anti-doping act criminalises trafficking in listed substances.
Approved medicines (7): Cerebrolysin, Gonadorelin, Liraglutide, Melanotan I, Oxytocin, Semaglutide, Tirzepatide
Restricted (13): AOD-9604, CJC-1295, GHRP-2, GHRP-6, Hexarelin, Ipamorelin, Kisspeptin, Melanotan II, MOTS-c, Sermorelin, TB-500, Tesamorelin, Thymosin beta-4
No specific ban (research reagent only) (15): BPC-157, Cagrilintide, DSIP, Epitalon, GHK-Cu, Humanin, KPV, LL-37, PT-141, Retatrutide, Selank, Semax, SS-31, Thymalin, Thymosin alpha-1
Portugal
Portugal does not schedule most peptides, but the Estatuto do Medicamento treats anything presented or intended for human use as an unauthorised medicine, and the 2021 anti-doping law (Lei 81/2021) criminalises supply of prohibited-list substances for any person — which captures many growth-hormone and anabolic peptides.
Approved medicines (6): Gonadorelin, Liraglutide, Melanotan I, Oxytocin, Semaglutide, Tirzepatide
Restricted (13): AOD-9604, Cerebrolysin, CJC-1295, GHRP-2, GHRP-6, Hexarelin, Ipamorelin, Kisspeptin, MOTS-c, Sermorelin, TB-500, Tesamorelin, Thymosin beta-4
No specific ban (research reagent only) (16): BPC-157, Cagrilintide, DSIP, Epitalon, GHK-Cu, Humanin, KPV, LL-37, Melanotan II, PT-141, Retatrutide, Selank, Semax, SS-31, Thymalin, Thymosin alpha-1
Belgium
Belgium treats genuinely lab-only, unscheduled peptides as chemicals under EU chemicals law (REACH/CLP). Anything presented or intended for human use is an unauthorised medicine, and public advertising of unapproved or prescription medicines carries criminal penalties.
Approved medicines (6): Gonadorelin, Liraglutide, Melanotan I, Oxytocin, Semaglutide, Tirzepatide
Restricted (13): AOD-9604, Cerebrolysin, CJC-1295, GHRP-2, GHRP-6, Hexarelin, Ipamorelin, Melanotan II, MOTS-c, Sermorelin, TB-500, Tesamorelin, Thymosin beta-4
No specific ban (research reagent only) (16): BPC-157, Cagrilintide, DSIP, Epitalon, GHK-Cu, Humanin, Kisspeptin, KPV, LL-37, PT-141, Retatrutide, Selank, Semax, SS-31, Thymalin, Thymosin alpha-1
Austria
Austria enforces strictly: the regulator (BASG) describes “research use only” labelling as a pretext and warns that even buyers of unapproved peptides face liability, so most non-approved peptides are treated as unauthorised medicines.
Approved medicines (7): Cerebrolysin, Gonadorelin, Liraglutide, Melanotan I, Oxytocin, Semaglutide, Tirzepatide
Restricted (13): AOD-9604, CJC-1295, GHRP-2, GHRP-6, Hexarelin, Ipamorelin, Kisspeptin, Melanotan II, MOTS-c, Sermorelin, TB-500, Tesamorelin, Thymosin beta-4
No specific ban (research reagent only) (15): BPC-157, Cagrilintide, DSIP, Epitalon, GHK-Cu, Humanin, KPV, LL-37, PT-141, Retatrutide, Selank, Semax, SS-31, Thymalin, Thymosin alpha-1
Sweden
Sweden’s Medical Products Agency (Läkemedelsverket) classifies many peptides — especially growth-hormone-axis ones — as prescription medicines, customs actively seizes imports, and the Doping Act criminalises possession or use of some anabolic substances.
Approved medicines (6): Gonadorelin, Liraglutide, Melanotan I, Oxytocin, Semaglutide, Tirzepatide
Restricted (12): AOD-9604, Cerebrolysin, CJC-1295, GHRP-2, GHRP-6, Hexarelin, Ipamorelin, Kisspeptin, Sermorelin, TB-500, Tesamorelin, Thymosin beta-4
No specific ban (research reagent only) (17): BPC-157, Cagrilintide, DSIP, Epitalon, GHK-Cu, Humanin, KPV, LL-37, Melanotan II, MOTS-c, PT-141, Retatrutide, Selank, Semax, SS-31, Thymalin, Thymosin alpha-1
Ireland
Ireland (HPRA) treats human-use-intended peptides as unauthorised medicines and actively enforces against grey-market sale and advertising; importation for human use requires a prescription.
Approved medicines (6): Gonadorelin, Liraglutide, Melanotan I, Oxytocin, Semaglutide, Tirzepatide
Restricted (2): Cerebrolysin, Melanotan II
No specific ban (research reagent only) (27): AOD-9604, BPC-157, Cagrilintide, CJC-1295, DSIP, Epitalon, GHK-Cu, GHRP-2, GHRP-6, Hexarelin, Humanin, Ipamorelin, Kisspeptin, KPV, LL-37, MOTS-c, PT-141, Retatrutide, Selank, Semax, Sermorelin, SS-31, TB-500, Tesamorelin, Thymalin, Thymosin alpha-1, Thymosin beta-4
United Kingdom
The UK (outside the EU since Brexit) runs its own medicines regime under the Human Medicines Regulations 2012, enforced by the MHRA. Most peptides are not controlled substances, so a genuine not-for-human-use research reagent is not in itself prohibited — but a peptide becomes a regulated medicine by presentation or intended human use, human growth hormone is a Class C controlled drug, and the MHRA has repeatedly named Melanotan II as illegal to sell.
Approved medicines (6): Gonadorelin, Liraglutide, Melanotan I, Oxytocin, Semaglutide, Tirzepatide
Restricted (2): Cerebrolysin, Melanotan II
No specific ban (research reagent only) (27): AOD-9604, BPC-157, Cagrilintide, CJC-1295, DSIP, Epitalon, GHK-Cu, GHRP-2, GHRP-6, Hexarelin, Humanin, Ipamorelin, Kisspeptin, KPV, LL-37, MOTS-c, PT-141, Retatrutide, Selank, Semax, Sermorelin, SS-31, TB-500, Tesamorelin, Thymalin, Thymosin alpha-1, Thymosin beta-4
Switzerland
Switzerland (outside the EU) regulates under the Therapeutic Products Act, enforced by Swissmedic, which classifies a substance as a medicine by its intended or objective use, not its label. There is no general research-chemical ban, so a bona fide reagent is not in itself illegal — but the anti-doping criminal law (SpoPA) prohibits manufacturing, importing, or selling listed doping substances even for non-athletes, with a strict no-allowance import ban.
Approved medicines (6): Gonadorelin, Liraglutide, Melanotan I, Oxytocin, Semaglutide, Tirzepatide
Restricted (13): AOD-9604, Cerebrolysin, CJC-1295, GHRP-2, GHRP-6, Hexarelin, Ipamorelin, Kisspeptin, MOTS-c, Sermorelin, TB-500, Tesamorelin, Thymosin beta-4
No specific ban (research reagent only) (16): BPC-157, Cagrilintide, DSIP, Epitalon, GHK-Cu, Humanin, KPV, LL-37, Melanotan II, PT-141, Retatrutide, Selank, Semax, SS-31, Thymalin, Thymosin alpha-1
Norway
Norway (EEA) applies EU medicines law: the Directorate for Medical Products (DMP) classifies a peptide by function or presentation, not by a “research use only” label, and treats bioactive peptides intended for human use as unapproved medicines, so import and sale are prohibited and customs seize parcels. Some compounds are specifically targeted — BPC-157 was added to the customs stop-list in 2025 and Melanotan II is named — and doping-list substances carry criminal penalties that can extend to personal use.
Approved medicines (5): Liraglutide, Melanotan I, Oxytocin, Semaglutide, Tirzepatide
Restricted (4): BPC-157, Cerebrolysin, Gonadorelin, Melanotan II
No specific ban (research reagent only) (26): AOD-9604, Cagrilintide, CJC-1295, DSIP, Epitalon, GHK-Cu, GHRP-2, GHRP-6, Hexarelin, Humanin, Ipamorelin, Kisspeptin, KPV, LL-37, MOTS-c, PT-141, Retatrutide, Selank, Semax, Sermorelin, SS-31, TB-500, Tesamorelin, Thymalin, Thymosin alpha-1, Thymosin beta-4
Czechia
Czechia has no research-chemical carve-out. SÚKL treats human-use-intended peptides as unregistered medicines, so selling them to the public is unlawful, and Criminal Code §288 criminalises supplying anabolic and hormonal substances — its “releasing factors” wording pulls growth-hormone-releasing peptides (GHRPs, CJC-1295) into the criminal net, and a 2025 amendment extended the list to incretin (GLP-1) agonists such as retatrutide. Unscheduled peptides outside these categories are not specifically banned.
Approved medicines (6): Cerebrolysin, Liraglutide, Melanotan I, Oxytocin, Semaglutide, Tirzepatide
Restricted (14): AOD-9604, CJC-1295, GHRP-2, GHRP-6, Gonadorelin, Hexarelin, Ipamorelin, Kisspeptin, MOTS-c, Retatrutide, Sermorelin, TB-500, Tesamorelin, Thymosin beta-4
No specific ban (research reagent only) (15): BPC-157, Cagrilintide, DSIP, Epitalon, GHK-Cu, Humanin, KPV, LL-37, Melanotan II, PT-141, Selank, Semax, SS-31, Thymalin, Thymosin alpha-1
Greece
Greece does not schedule peptides under its narcotics code, so an unscheduled, non-anabolic peptide is not a controlled substance — but the EU medicine-by-function rule means anything intended for human use is an unauthorised medicine (EOF), and growth-hormone and anabolic peptides are caught by the anti-doping framework.
Approved medicines (5): Liraglutide, Melanotan I, Oxytocin, Semaglutide, Tirzepatide
Restricted (15): AOD-9604, Cerebrolysin, CJC-1295, GHRP-2, GHRP-6, Gonadorelin, Hexarelin, Ipamorelin, Kisspeptin, Melanotan II, MOTS-c, Sermorelin, TB-500, Tesamorelin, Thymosin beta-4
No specific ban (research reagent only) (15): BPC-157, Cagrilintide, DSIP, Epitalon, GHK-Cu, Humanin, KPV, LL-37, PT-141, Retatrutide, Selank, Semax, SS-31, Thymalin, Thymosin alpha-1
Denmark
Denmark (Lægemiddelstyrelsen) offers no research-chemical safe harbour: human-use-intended peptides are unauthorised medicines, and the Doping Act criminalises possession and supply of anabolic and similar substances, which remain excluded from any 2026 import relaxation. Specific compounds such as Melanotan II are named as illegal.
Approved medicines (5): Liraglutide, Melanotan I, Oxytocin, Semaglutide, Tirzepatide
Restricted (14): AOD-9604, Cerebrolysin, CJC-1295, GHRP-2, GHRP-6, Gonadorelin, Hexarelin, Ipamorelin, Kisspeptin, Melanotan II, Sermorelin, TB-500, Tesamorelin, Thymosin beta-4
No specific ban (research reagent only) (16): BPC-157, Cagrilintide, DSIP, Epitalon, GHK-Cu, Humanin, KPV, LL-37, MOTS-c, PT-141, Retatrutide, Selank, Semax, SS-31, Thymalin, Thymosin alpha-1
Prohibited in sport (WADA)
These 13 compounds are on the World Anti-Doping Agency Prohibited List, so a competing athlete can fail a drug test for them. This is a sporting-eligibility matter, separate from legality: it does not by itself make a compound illegal to possess or handle, and it does not make human use lawful (it never is, without authorisation).
AOD-9604, CJC-1295, GHRP-2, GHRP-6, Gonadorelin, Hexarelin, Ipamorelin, Kisspeptin, MOTS-c, Sermorelin, TB-500, Tesamorelin, Thymosin beta-4
Frequently asked questions
- Are peptides legal in Europe?
- Human use is the key line: any peptide intended for human use is an unauthorised medicine, which is not lawful without a marketing authorisation. As research reagents it depends on the compound and country — many unapproved peptides are not specifically scheduled and so are not in themselves prohibited to handle as genuine, not-for-human-use laboratory reagents, while growth-hormone and anabolic peptides are restricted across most of Europe. This is educational, not legal advice; check current local law.
- Does a “research use only” label make a peptide legal?
- No. EU medicines law classifies a substance by its intended use, not its label. A “not for human consumption” label only describes genuine laboratory use; it does not make human use lawful.
- Why does the same peptide have a different legal status in different countries?
- There is no single Europe-wide research-chemical law. Some countries — Germany, Austria, Italy, France and Sweden among the strictest — treat most non-approved peptides as unauthorised medicines, while others have not specifically scheduled them, so a compound can be unscheduled in one market and restricted in another. Unscheduled never means lawful for human use.
- Which peptides are restricted across Europe?
- Growth-hormone-axis and anabolic peptides — the GHRPs, CJC-1295, sermorelin, tesamorelin and similar — are restricted in the markets that criminalise anti-doping substances beyond sport (most, but not all). Melanotan II is restricted separately, as a named illegal medicine rather than a doping agent. Many of these are also prohibited in sport (WADA), which is a distinct matter from legality. This is educational, not legal advice; check current local law.
- Is BPC-157 legal in Europe?
- Human use of BPC-157 is never lawful — it is treated as an unauthorised medicine everywhere in Europe and is not an approved medicine anywhere. As a research reagent it is not specifically scheduled in most markets, but it is specifically restricted in Norway, where it was added to the customs stop-list in 2025. This is educational, not legal advice; check current local law.
- Which European countries are strictest on peptides?
- Germany, Austria, Italy, France and Sweden apply medicines and anti-doping law most aggressively, treating most non-approved peptides as unauthorised medicines and rejecting the “research use only” label. Some other markets have not specifically scheduled many of these compounds — but human use is treated as an unauthorised medicine everywhere.
- Does “prohibited in sport (WADA)” mean a peptide is illegal?
- No. The WADA Prohibited List governs what competing athletes may use; being on it does not by itself make a substance illegal to possess or handle. Several compounds here are prohibited in sport but not otherwise legally restricted in many markets. Where a country has turned anti-doping rules into criminal law that reaches the general public, that is shown as “restricted” for that country — which is a separate fact from the sport flag. Human use remains an unauthorised medicine everywhere, which is a separate bar again.